CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, GHRPs, IGF-1 analogs, and GH-axis research.
A research-grade guide to PEG-MGF, the PEGylated C-terminal E-domain peptide of Mechano Growth Factor (the IGF-1Ec splice variant), and the contested preclinical literature behind it.
PEG-MGF Research Guide: Mechano Growth Factor and the IGF-1 Splice Variant Read More ยป
A research-grade comparison of GHRP-2, GHRP-6, and Hexarelin — three synthetic hexapeptide ghrelin-receptor (GHSR-1a) agonists — across sequence, potency, appetite signaling, cross-axis hormones, and Hexarelin\’s CD36 cardiac mechanism.
GHRP-2 vs GHRP-6 vs Hexarelin: Growth Hormone Secretagogue Comparison Read More ยป
A research-grade profile of tesamorelin, the stabilized GHRH(1-44) analog: trans-3-hexenoyl modification, GHRH-receptor mechanism, pharmacokinetics, and how it differs from sermorelin.
Tesamorelin Research Guide: Stabilized GHRH(1-44) Analog Read More ยป
A research-grade overview of IGF-1 LR3: its 83-residue Long-R3 architecture, IGF-1R signaling, the IGFBP-binding design rationale, and how it differs from native IGF-1.
IGF-1 LR3 Research Guide: Structure, Mechanism & IGFBP Design Read More ยป
Sermorelin Research Guide: GHRH 1-29 Mechanism, Geref® FDA History & Research Applications Quick Answer Sermorelin is a synthetic 29-amino-acid peptide, the minimal receptor-active N-terminal fragment (GHRH 1-29) of the parent 44-residue human growth hormone-releasing hormone characterized at the Salk Institute in 1982. It acts as a selective agonist of the GHRH receptor (GHRHR) on anterior
Sermorelin Research Guide Read More ยป
Binary GHRH analog comparison of Tesamorelin (stabilized GHRH(1-44); FDA-approved Egrifta) and Sermorelin (GHRH(1-29)NH2 fragment; previously-approved Geref) โ a dual-registrational-pedigree pair.
Tesamorelin vs Sermorelin: Comparing GHRH Analogs Read More ยป
Receptor-pathway comparison of Ipamorelin (selective GHS-R1a pentapeptide) and CJC-1295 (tetra-substituted GHRH(1-29) analog) covering supra-additive synergy and the canonical combination research preparation.
Ipamorelin vs CJC-1295: GHS vs GHRH Receptor Compared Read More ยป
Cascade-anchored reference to GH-axis research peptides โ Sermorelin, Tesamorelin, CJC-1295, Ipamorelin, and the full fourteen-compound catalog โ across five mechanism families with research-context regulatory framing.
Growth Hormone Peptides: GHRH Analogs & Secretagogues Read More ยป
Detailed comparison of Sermorelin vs CJC-1295 (Mod GRF 1-29) for GH-axis research. Molecular differences, DPP-4 resistance, half-life profiles, published pharmacokinetic data, combination protocols with Ipamorelin, and Tesamorelin comparison.
Sermorelin vs CJC-1295: Which GHRH Analog for Your Research? Read More ยป
Complete CJC-1295 research guide explaining the critical difference between CJC-1295 with DAC and CJC-1295 without DAC (Mod GRF 1-29). GHRH receptor mechanism, pulsatile vs sustained GH release patterns, combination research with Ipamorelin, and published pharmacokinetic data.
CJC-1295 Research Guide: With DAC vs Without DAC Explained Read More ยป
Comprehensive research guide to Ipamorelin, the selective growth hormone secretagogue. CAS 170851-70-4, MW 711.85 g/mol. GHSR-1a selectivity mechanism, published pharmacology, combination research with CJC-1295, and comparison to GHRP-2 and GHRP-6.
Ipamorelin Research Guide: The Selective Growth Hormone Secretagogue Read More ยป
Same day shipping
Multiple payment options
Real-time order tracking
Weโre here to help
Apex Laboratory is a specialized supplier of high-purity chemical reagents and peptides. All products listed are strictly for in-vitro laboratory research and development use only.
support@apexlaboratory.org
Mon – Fri
09:00 – 17:00 EST
